Page last updated: 2024-08-23

amikacin and trovafloxacin

amikacin has been researched along with trovafloxacin in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (33.33)	18.2507
2000's	3 (50.00)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Milatovic, D; Wallrauch, C	1
Appelbaum, PC; Bajaksouzian, S; Jacobs, MR; Visalli, MA	1
Burgess, DS; Hastings, RW	1
Borner, K; Brodersen, B; Koeppe, P; Lode, H; Lubasch, A; Ziege, S	1

Reviews

1 review(s) available for amikacin and trovafloxacin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for amikacin and trovafloxacin

Article	Year
Serum bactericidal activity of trovafloxacin, in combination with cefepime or amikacin, in healthy volunteers. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:7 Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefepime; Cephalosporins; Cross-Over Studies; Female; Fluoroquinolones; Humans; Male; Naphthyridines	2003

Article

Year

Serum bactericidal activity of trovafloxacin, in combination with cefepime or amikacin, in healthy volunteers.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:7

Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefepime; Cephalosporins; Cross-Over Studies; Female; Fluoroquinolones; Humans; Male; Naphthyridines

2003

Other Studies

4 other study(ies) available for amikacin and trovafloxacin

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
In vitro activity of trovafloxacin in combination with ceftazidime, meropenem, and amikacin. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1996, Volume: 15, Issue:8 Topics: Amikacin; Anti-Infective Agents; Bacteria; Ceftazidime; Drug Therapy, Combination; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Naphthyridines; Thienamycins	1996
Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:7 Topics: Amikacin; Anti-Infective Agents; Ceftazidime; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Bacteria; Imipenem; Microbial Sensitivity Tests; Naphthyridines; Titrimetry	1997
Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill. Diagnostic microbiology and infectious disease, 2000, Volume: 38, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Chi-Square Distribution; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Fluoroquinolones; Humans; Naphthyridines; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2000